A novel machine learning model to predict high on-treatment platelet reactivity on clopidogrel in Asian patients after percutaneous coronary intervention
ConclusionA ML-based approach, such as XGBoost, showed optimum performance and might help predict HTPR on clopidogrel after PCI and guide clinical decision-making. Further validated studies will strengthen this finding.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | China Health | Clopidogrel | Coronary Angioplasty | Drugs & Pharmacology | Genetics | Learning | Percutaneous Coronary Intervention | Plavix | Study | Training | Universities & Medical Training